Aspirin may be effective in reducing the risk of melanoma for some women, says a new study from researchers at the Stanford University School of Medicine. For the study the researchers examined the health records of 60,000 postmenopausal Caucasian women between the ages of 50 and 79.
Each participant in the study had been surveyed about their daily medication use. They found that those women who used aspirin two to three times a week were twenty-one percent less likely to develop melanoma.
“Aspirin works on a slightly different inflammatory pathway than NSAIDs, and some of these pathways may be specific to melanoma,” said lead researcher Dr. Jean Tang. “Aspirin could be used as a way to prevent melanoma, however clinical trial testing has to be done first before it can be recommended.”
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comHealth News